Form 4: NRC Health Director Receives Equity Award
Insider Transaction
NRC Health Director Stephen H. Lockhart was granted restricted stock units valued at $150,000, vesting in 2027.
Summary
- Stephen H. Lockhart, a Director at NRC Health, received an equity award on June 23, 2026.
- The award consists of restricted stock units (RSUs) with a total value of $150,000.
- The number of RSUs granted was calculated by dividing $150,000 by the closing stock price on the day before the Issuer's 2026 annual meeting.
- These RSUs are part of the Issuer's 2025 Omnibus Incentive Plan.
- The award is subject to vesting, forfeiture, and termination provisions.
- The RSUs will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting.
- Following the transaction, Mr. Lockhart beneficially owns 7,697 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity award to a director rather than a significant financial event or strategic shift.
Positives
- Director Lockhart received a significant equity award, indicating continued investment in leadership and alignment with shareholder interests.
- The award is structured under the company's incentive plan, suggesting a formal and established compensation framework.
- The direct ownership of 7,697 shares post-transaction shows a tangible stake in the company.
Risks
- The value of the award is tied to the company's stock price, meaning its ultimate worth is subject to market fluctuations.
- Vesting, forfeiture, and termination provisions introduce potential risks of losing the award if certain conditions are not met.
Future Outlook
The restricted stock units granted to Director Lockhart will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination provisions.
Industry Context
StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare technology sector to align executive interests with long-term shareholder value. The structure of this award, tied to stock price and vesting over time, is typical for incentivizing sustained performance.
Stakeholder Impact
- Shareholders: The equity award aligns director compensation with shareholder interests and the company's stock performance.
- Employees: The award is part of the company's incentive plan, which may also apply to other employees, signaling a focus on performance-based compensation.
- Management: Reinforces the alignment of the board with the company's strategic goals and financial performance.
Next Steps
- The restricted stock units will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting.
Key Dates
| Date | Description |
|---|---|
| 06/23/2026 | Earliest transaction date and date of equity award grant. |
| 2026 | Year of the Issuer's annual meeting of stockholders, used for calculating the RSU grant price. |
| 2027 | Year of the Issuer's annual stockholder meeting, when the award will vest and become exercisable. |
Keywords
NRC Health, Form 4, Insider Trading, Equity Award, Restricted Stock Units, Stephen H. Lockhart, Director Compensation, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.